期刊文献+

生物羊膜+重组人表皮生长因子治疗创伤性鼓膜穿孔的疗效 被引量:1

Effect of Bioamnion Plus Recombinant Human Epidermal Growth Factor on Traumatic Perforation of Tympanic Membrane
下载PDF
导出
摘要 目的探讨耳显微镜下运用生物羊膜+重组人表皮生长因子(recombinant human epidermal growth factor,rhEGF)治疗创伤性鼓膜穿孔的疗效。方法48例(48耳)创伤性鼓膜穿孔患者,均采用在耳显微镜下运用生物羊膜+rhEGF治疗,分别于术后2周、1个月、3个月对患者进行随访,观察鼓膜愈合情况;术后1、3个月复诊时进行纯音测听检查评估听力情况,评估疗效。结果治愈46例,好转1例,无效1例,有效率为97.9%。1例好转与1例无效的患者经同样方法行第2次手术治疗后痊愈。结论耳显微镜下运用生物羊膜+rhEGF治疗创伤性鼓膜穿孔有取材方便、操作简单、成活率高、安全有效等优点。 Objective To investigate the effect of bioamnion plus recombinant human epidermal growth factor(rhEGF) on traumatic tympanic membrane perforation under the otomicroscope. Methods A total of 48 cases of traumatic tympanic membrane perforation (48 ears) were treated with bioamniotic membrane and rhEGF under the otomicroscope.Patients were followed up for 2 weeks,1 month and 3 months to observe the healing of tympanic membrane perforation.The pure-tone audiometry was performed to assess the hearing ability 1 and 3 months after operation. Results Among the 48 patients,complete cure was achieved in 46.In addition,the symptom was improved in 1 patient and the treatment was ineffective in 1 patient.The efficiency is 97.9%.The two patients were cured after the second operation. Conclusion The treatment with bioamnion and rhEGF under otomicroscope is convenient,simple,safe and effective for traumatic tympanic membrane perforation.
作者 张红奇 李梅 顾丽群 ZHANG Hong-qi;LI Mei;GU Li-qun(Department of Otorhinolaryngology,Jianhu Jianyang Ophthalmic Hospital,Yancheng 224700,China;Department of Otorhinolaryngology,Eye and ENT Hospital of Suzhou,Suzhou 215006,China)
出处 《实用临床医学(江西)》 CAS 2019年第7期59-60,68,共3页 Practical Clinical Medicine
关键词 生物羊膜 重组人表皮生长因子 鼓膜穿孔 创伤 疗效 bioamnion recombinant human epidermal growth factor tympanic membrane perforation trauma curative effect
  • 相关文献

参考文献7

二级参考文献63

共引文献32

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部